secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001104659-24-002975
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos shareholders approve 25x increase in authorized shares, ratify Lind Global note issuance
--------------------------------------------------------------------------------

- Authorized common shares increased from 16M to 400M via Certificate of Amendment filed Jan 10, 2024.
- Stockholders approved issuance of >20% of outstanding common stock under $22M convertible note with Lind Global (Convertible Note Proposal).
- Vote on authorized share increase: 5,189,686 for, 1,101,134 against, 27,944 abstain.
- Vote on convertible note proposal: 3,005,989 for, 698,838 against, 1,051,469 abstain, 1,562,468 broker non-votes.
- Amendment does not alter voting rights but enables future dilution from additional share issuances.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000110465924002975/0001104659-24-002975-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000110465924002975/tm242612d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-002975

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer